Correlation Between Cisco Systems and PharmChem

Can any of the company-specific risk be diversified away by investing in both Cisco Systems and PharmChem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cisco Systems and PharmChem into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cisco Systems and PharmChem, you can compare the effects of market volatilities on Cisco Systems and PharmChem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cisco Systems with a short position of PharmChem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cisco Systems and PharmChem.

Diversification Opportunities for Cisco Systems and PharmChem

-0.63

Correlation Coefficient

Cisco Systems  PharmChem

Excellent diversification

The 3 months correlation between Cisco and PharmChem is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Cisco Systems and PharmChem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmChem and Cisco Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cisco Systems are associated (or correlated) with PharmChem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmChem has no effect on the direction of Cisco Systems i.e., Cisco Systems and PharmChem go up and down completely randomly.

Pair Corralation between Cisco Systems and PharmChem

Given the investment horizon of 90 days Cisco Systems is expected to generate 0.32 times more return on investment than PharmChem. However, Cisco Systems is 3.08 times less risky than PharmChem. It trades about 0.25 of its potential returns per unit of risk. PharmChem is currently generating about -0.08 per unit of risk. If you would invest  5,019  in Cisco Systems on September 18, 2024 and sell it today you would earn a total of  816.00  from holding Cisco Systems or generate 16.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.41%
Values	Daily Returns

Cisco Systems  vs.  PharmChem

Cisco Systems

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Cisco Systems are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile fundamental indicators, Cisco Systems displayed solid returns over the last few months and may actually be approaching a breakup point.

PharmChem

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PharmChem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Cisco Systems and PharmChem

The main advantage of trading using opposite Cisco Systems and PharmChem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cisco Systems position performs unexpectedly, PharmChem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmChem will offset losses from the drop in PharmChem's long position.

The idea behind Cisco Systems and PharmChem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.